A comparison of the quality of life in patients with severe ulcerative colitis after total colectomy versus medical treatment with intravenous cyclosporin

Inflammatory Bowel Diseases

Volumn 5, Issue 1, 1999, Pages 1-10

  Cohen, Russell D ^a   Brodsky, Amy L ^a   Hanauer, Stephen B ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

Colectomy; Cyclosporin; Drug therapy; Health care outcomes; Quality of life; Ulcerative colitis

Indexed keywords

CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; CLINICAL TRIAL; COLON RESECTION; COLONOSCOPY; COMPARATIVE STUDY; FEMALE; HEALTH SERVICE; HOSPITALIZATION; HUMAN; INFORMATION PROCESSING; INTRAVENOUS DRUG ADMINISTRATION; MALE; MIDDLE AGED; NONPARAMETRIC TEST; PATIENT SATISFACTION; PROGNOSIS; QUALITY OF LIFE; QUESTIONNAIRE; ULCERATIVE COLITIS; UNITED STATES; UTILIZATION REVIEW;

ADULT; COLECTOMY; COLITIS, ULCERATIVE; COLONOSCOPY; CYCLOSPORINE; DATA COLLECTION; FEMALE; HEALTH SERVICES; HOSPITALIZATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; PATIENT SATISFACTION; PROGNOSIS; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; UNITED STATES;

EID: 0033070414     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1097/00054725-199902000-00001     Document Type: Review

References (21)

1. Edwards FC, Truelove SC. The course and prognosis of ulcerative colitis. I. Short-term prognosis. Gut 1964;4:299.
2. Köhler LW, Pemberton JH, Zinsmeister AR, Kelly KA. Quality of life after proctocolectomy. A comparison of Brooke ileostomy, Kock pouch, and ileal pouch-anal anastomosis. Gastroenterology 1991;101:679-84.
3. McLeod RS, Churchill DN, Lock AM, Vanderburgh S, Cohen Z. Quality of life of patients with ulcerative colitis preoperatively and postoperatively. Gastroenterology 1991;101:1307-13.
4. Lichtiger S, Present DH, Kombluth A, Gelernt I, Bauer J, Galler G, Michelassi F, Hanauer S. Cyclosporin in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 1994;330:1841-5.
5. Kornbluth A, Lichtiger S, Present D, Hanauer S. Long-term results of oral cyclosporin in patients with severe ulcerative colitis: a double-blind, randomized, multi-center trial. Gastroenterology 1994;106:A714.
6. Baert F, Hanauer S. CYA in severe steroid-resistant UC: long-term results of therapy. Gastroenterology 1994;106:A648.
7. Sagar PM, Lewis W, Holdsworth PJ, Johnston D, Mitchell C, MacFie J. Quality of life after restorative proctocolectomy with a pelvic ileal reservoir compares favorably with that of patients with medically treated colitis. Dis Colon Rectum 1993;36:584-92.
8. Guyatt G, Mitchell A, Irvine EJ, Singer J, Williams N, Goodacre R, Tompkins C. A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology 1989;96:804-10.
9. Irvine EJ, Feagan B, Rochon J, Archambault A, Fedorak RN, Groll A, Kinnear D, Saibil F, McDonald JWD for the Canadian Crohn's Relapse Prevention Trial. Quality of life: a valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. Gastroenterology 1994;106:287-96.
10. Greenberg GR, Feagan BG, Martin F, Sutherland LR, Thomson ABR, Williams CN, Nilsson LG, Persson T, and the Canadian Inflammatory Bowel Disease Study Group. Oral budesonide for active Crohn's disease. N Engl J Med 1994;331:836-41.
11. Feagan BG, Rochon J, Fedorak RN, Irvine EJ, Wild G, Sutherland L, Steinhart AH, Greenberg GR, Gillies R, Hopkins M, Hanauer SB, McDonald JWD for the North American Crohn's Study Group Investigators. Methotrexate for the treatment of Crohn's disease. N Engl J Med 1995;332:292-7.
12. Singleton JW, Hanauer SB, Gitnick GL, Peppercorn MA, Robinson MG, Wruble LD, Krawitt EL, and the Pentasa Crohn's Disease Study Group. Mesalamine capsules for the treatment of active Crohn's disease: results of a 16-week trial. Gastroenterology 1993; 104:1293-301.
13. Robinson M, Hanauer S, Hoop R, Zbrozek A, and Wilkinson C. Mesalamine capsules enhance the quality of life for patients with ulcerative colitis. Aliment Pharmacol Ther 1994;8:27-34.
14. Zbrozek A, Hoop R, Robinson M, Wilkinson C. Testing an instrument to measure the function-related quality of life of patients with inflammatory bowel disease. Gastroenterology 1991;100:A264.
15. Zbrozek A, Hopp R, Robinson MG, McPherson M. Text of an instrument to measure function-related quality of life in patients with ulcerative colitis. Pharmacoeconomics 1993;4:31-9.
16. Öresland R, Fasth S, Nordgren S, Hultén L. The clinical and functional outcome after restorative proctocolectomy. A prospective study in 100 patients. Int J Colorect Dis 1989;4:50-6.
17. Köhler LW, Pemberton JH, Hodge DO, Zinsmeister AR, Kelly KA. Long-term functional results and quality of life after ileo pouch-anal anastomosis and cholecystectomy. World J Surg 1992; 16:1126-32.
18. Mallett SJ, Lennard-Jones JE, Bingley J, Gilon E. Living with disease. Colitis. Lancet 1978;2:619-21.
19. Meyers S, Walfish JS, Sachar DB, Greenstein AJ, Hill AG, Janow-itz HD. Quality of life after surgery for Crohn's disease: a psychological survey. Gastroenterology 1980;78:1-6.
20. Drossman DA, Patrick DL, Mitchell CM, Zagami EA, Appelbaum MI. Health-related quality of life in inflammatory bowel disease. Functional status and patient worries and concerns. Dig Dis Sci 1989;34:1379-86.
21. Turnbull GK, Vallis TM. Quality of life in inflammatory bowel disease: the interaction of disease activity with psychosocial function. Am J Gastroenterol 1995;90:1450-4.